Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Dieldrin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Lindane inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Picrotoxin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
tert-butylbicyclo-2-benzoate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C006477 |
alphaxalone |
alphaxalone promotes the reaction [Flunitrazepam binds to GABRA2 protein] | affects binding|increases reaction | 8397295
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein] | affects cotreatment|increases activity | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GABRA2 mRNA | affects expression | 16483693
|
C459604 |
candoxin |
candoxin results in increased expression of GABRA2 mRNA | increases expression | 16309724
|
D002330 |
Carmustine |
Carmustine results in decreased expression of GABRA2 mRNA | decreases expression | 15980968
|
D002712 |
Chlorides |
[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
D003975 |
Diazepam |
GABRA2 protein affects the susceptibility to Diazepam | affects response to substance | 18313124
|
D003975 |
Diazepam |
GABRA2 protein results in increased susceptibility to Diazepam | increases response to substance | 16284244
|
D003975 |
Diazepam |
Diazepam results in increased activity of GABRA2 protein | increases activity | 15613639
|
D004026 |
Dieldrin |
Dieldrin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D000431 |
Ethanol |
Ethanol results in decreased expression of GABRA2 mRNA | decreases expression | 1711815
|
C044610 |
etizolam |
etizolam affects the expression of GABRA2 mRNA | affects expression | 16107249
|
D005445 |
Flunitrazepam |
alphaxalone promotes the reaction [Flunitrazepam binds to GABRA2 protein] | affects binding|increases reaction | 8397295
|
D005445 |
Flunitrazepam |
Flunitrazepam binds to GABRA2 protein | affects binding | 8397295
|
D005445 |
Flunitrazepam |
Pentobarbital promotes the reaction [Flunitrazepam binds to GABRA2 protein] | affects binding|increases reaction | 8397295
|
D005445 |
Flunitrazepam |
Flunitrazepam results in increased activity of GABRA2 protein | increases activity | 16162846
|
D001556 |
Lindane |
Lindane inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D008140 |
Lorazepam |
Lorazepam affects the expression of GABRA2 mRNA | affects expression | 16107249
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in increased expression of GABRA2 mRNA | increases expression | 15585362
|
D010424 |
Pentobarbital |
GABRA2 protein affects the susceptibility to Pentobarbital | affects response to substance | 18313124
|
D010424 |
Pentobarbital |
Pentobarbital promotes the reaction [Flunitrazepam binds to GABRA2 protein] | affects binding|increases reaction | 8397295
|
D010433 |
Pentylenetetrazole |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010852 |
Picrotoxin |
Picrotoxin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D011374 |
Progesterone |
Progesterone results in increased expression of GABRA2 mRNA | increases expression | 16000229
|
C042957 |
Ro 15-4513 |
GABRA2 protein affects the susceptibility to Ro 15-4513 | affects response to substance | 15850489
|
C446685 |
systhane |
systhane results in decreased expression of GABRA2 mRNA | decreases expression | 16730040
|
C046308 |
tert-butylbicyclo-2-benzoate |
tert-butylbicyclo-2-benzoate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D043343 |
Testosterone Propionate |
Testosterone Propionate results in decreased expression of GABRA2 mRNA | decreases expression | 16957604
|
D014050 |
Toluene |
Toluene affects the expression of GABRA2 mRNA | affects expression | 17108153
|
C052342 |
topiramate |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
C032910 |
triadimefon |
triadimefon results in decreased expression of GABRA2 mRNA | decreases expression | 16730040
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
3.69 | 18926900 17676605 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.71 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.71 | 11192467 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
4.15 | 12661182 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.09 | 15451039 15451040 |
MESH:D000437 |
Alcoholism |
marker/mechanism |
|
| |
MESH:D000437 |
Alcoholism |
|
topiramate |
4.85 | 17925516 18552399 19331489 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.59 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
marker/mechanism |
|
| 18313124 |
MESH:D001008 |
Anxiety Disorders |
|
Diazepam |
14.19 | 16284244 18313124 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
14.19 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
14.19 | 18313124 11141031 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18821008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.11 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.03 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.19 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
2.22 | 15770527 11859874 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
2.22 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.22 | 17614352 15562024 16175315 |
MESH:D002056 |
Burns |
|
Ethanol |
4.43 | 16374292 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
2.37 | 15763234 18788625 15289165 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
3.31 | 19332462 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.62 | 9294310 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
topiramate |
4.01 | 15650499 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.47 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Diazepam |
9.74 | 3629520 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
9.74 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
9.74 | 16781842 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
4.04 | 11198716 15451040 10194807 11873399 19302082 15513904 15451039 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
4.04 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
4.04 | 16875885 15834900 |
MESH:D003643 |
Death |
|
Pentylenetetrazole |
13.12 | 6431079 |
MESH:D003643 |
Death |
|
Toluene |
13.12 | 6431079 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
topiramate |
3.64 | 16979414 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.27 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
2.55 | 11566570 |
MESH:D004421 |
Dystonia |
|
Diazepam |
5.46 | 1851702 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.56 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.57 | 16134523 |
MESH:D004828 |
Epilepsies, Partial |
|
Diazepam |
5.31 | 3922381 |
MESH:D004827 |
Epilepsy |
|
Diazepam |
7.40 | 821787 |
MESH:D004827 |
Epilepsy |
|
topiramate |
7.40 | 19148780 |
MESH:D004832 |
Epilepsy, Absence |
|
Diazepam |
9.60 | 6426943 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Pentylenetetrazole |
9.60 | 6426943 |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
topiramate |
6.04 | 16499746 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.70 | 16704527 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
3.53 | 19236843 18620774 16409862 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.43 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.07 | 16946407 15513904 10194807 15451040 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.46 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
3.78 | 16187019 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
8.77 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
8.77 | 17178688 17178689 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.54 | 18783367 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.18 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
4.73 | 10630421 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.49 | 15869954 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
10.03 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
10.03 | 15834900 15992940 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.99 | 15451040 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.65 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.25 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.87 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
2.30 | 18166357 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
4.65 | 1715830 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
4.65 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.43 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
5.12 | 9539021 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
5.12 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
6.40 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
6.40 | 17178689 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.73 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
Carmustine |
2.84 | 12393984 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.97 | 18411066 15451040 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.57 | 9294310 |
MESH:D008881 |
Migraine Disorders |
|
topiramate |
4.42 | 18759728 18803445 16942474 18765137 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
5.02 | 9294310 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
5.45 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Lindane |
5.45 | 16818664 12807735 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.46 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.89 | 12384795 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.44 | 11445065 11181820 16809432 17291500 16112328 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
4.23 | 12661182 14688026 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.79 | 10930210 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
MESH:D012640 |
Seizures |
|
Diazepam |
40.40 | 15946322 9754883 10087439 |
MESH:D012640 |
Seizures |
|
Ethanol |
40.40 | 9754883 |
MESH:D012640 |
Seizures |
|
etizolam |
40.40 | 16107249 |
MESH:D012640 |
Seizures |
|
Lindane |
40.40 | 12842176 15475178 7539098 |
MESH:D012640 |
Seizures |
|
Lorazepam |
40.40 | 16107249 10087439 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
40.40 | 9754883 10087439 |
MESH:D012640 |
Seizures |
|
Pentylenetetrazole |
40.40 | 19660546 16054440 6431079 8954991 2616065 3037702 3352866 18657176 15475178 18164287 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
40.40 | 8635557 8954991 |
MESH:D012640 |
Seizures |
|
Toluene |
40.40 | 6431079 9294310 |
MESH:D012640 |
Seizures |
|
topiramate |
40.40 | 16499746 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Lorazepam |
6.03 | 15341891 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.05 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.33 | 17189318 11906479 9562338 17918041 16755016 9211565 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Diazepam |
15.57 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
15.57 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
15.57 | 11529278 9754883 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.73 | 10514026 10048760 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
3.92 | 17178689 |